TET2 and acute myeloid leukemia: However, loss-of-function TET2 variants are common in clonal hematopoiesis and predominate in AML of older adults, while IDH1/2 mutations are uncommon in CHIP, yet when such clones do arise they carry a markedly elevated risk of progression to overt leukemia [32].